General Framework for the Quantitative Prediction of CYP3A4-Mediated Oral Drug Interactions Based on the AUC Increase by Coadministration of??Standard Drugs-Reference-Cited by-同舟云学术

General Framework for the Quantitative Prediction of CYP3A4-Mediated Oral Drug Interactions Based on the AUC Increase by Coadministration of??Standard Drugs

Published:2007 Issue:8 Volume:46 Page:681-696
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clinical Pharmacokinetics

Author:

Ohno Yoshiyuki,Hisaka Akihiro,Suzuki Hiroshi

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Reference125 articles.

1. Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors

2. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450–metabolized drugs

3. H1-receptor antagonists: safety issues

4. Sorivudine and 5‐fluorouracil; a clinically significant drug‐drug interaction due to inhibition of dihydropyrimidine dehydrogenase

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism-based inactivation of cytochromes P450: implications in drug interactions and pharmacotherapy;Xenobiotica;2024-08-28

2. Clinical Trial Data-Driven Risk Assessment of Drug–Drug Interactions: A Rapid and Accurate Decision-Making Tool;Clinical Pharmacokinetics;2024-08

3. Evaluation of Sources of Drug Interaction Information for Nirmatrelvir/ritonavir;YAKUGAKU ZASSHI;2024-07-01

4. A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B6;Journal of Pharmacological and Toxicological Methods;2024-05

5. Phenotypic Models of Drug–Drug‐Gene Interactions Mediated by Cytochrome Drug‐Metabolizing Enzymes;Clinical Pharmacology & Therapeutics;2024-02-06